As a result of the investment, the Tjoapack facility will increase from 8,500 m2 to 11,500 m2 and will see the addition of eight new production lines to double capacity for primary packaging for oral solids to over four billion tablets per year.
In addition to the increase in its production capacity, Tjoapack will also be investing heavily in its warehousing and cold chain capabilities to meet increased customer demand for its added value logistics services.
Comments from CEO
Dexter Tjoa, CEO at Tjoapack remarked, “This latest investment is driven by growing industry demand for our high-quality services and is the latest stage in our ambitious growth plans. The expansion will not only increase our capacity but also bolster our supply chain and logistics services.
“Our strategic location in the Breda area, Netherlands allows us to act as a gateway to Europe for many of our clients and investing in our logistics capabilities is a natural next step in our journey.”
This latest expansion follows Tjoapack’s recent investment into its automated packaging capabilities for pre-filled syringes and vials.
Tjoa added, “We remain committed to shaping the future of the pharmaceutical supply chain and we continue to work to develop and refine our offering, as well as incorporate the latest innovations, to reduce time to market for our customer base.
“We’re confident this two-year expansion plan will allow us to ensure we can continue to react fast and flexibly to the needs of our customers, as well as cater for larger, diverse and more complex projects.”
The expansion will also see the Tjoapack team almost double with the appointment of over 100 new employees.
Founded in 1989, Tjoapack specializes in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has a total of 18 packaging lines for blisters, bottles, and vials. Using these lines, it packages around 35 million packs of pharmaceutical products per year.